113 related articles for article (PubMed ID: 2133286)
1. Priming of human monocytes with PAF augments their production of tumor necrosis factor.
Rola-Pleszczynski M
J Lipid Mediat; 1990; 2 Suppl():S77-82. PubMed ID: 2133286
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.
Poubelle PE; Gingras D; Demers C; Dubois C; Harbour D; Grassi J; Rola-Pleszczynski M
Immunology; 1991 Feb; 72(2):181-7. PubMed ID: 2016118
[TBL] [Abstract][Full Text] [Related]
3. Effects of platelet-activating factor on peripheral blood monocytes: induction and priming for TNF secretion.
Bonavida B; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S65-76. PubMed ID: 2133285
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory functions of paf-acether. IV. Enhancement of IL-1 production by muramyl dipeptide-stimulated monocytes.
Salem P; Deryckx S; Dulioust A; Vivier E; Denizot Y; Damais C; Dinarello CA; Thomas Y
J Immunol; 1990 Feb; 144(4):1338-44. PubMed ID: 2105995
[TBL] [Abstract][Full Text] [Related]
5. Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha.
Sancéau J; Falcoff R; Beranger F; Carter DB; Wietzerbin J
Immunology; 1990 Jan; 69(1):52-6. PubMed ID: 1690177
[TBL] [Abstract][Full Text] [Related]
6. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.
Hart PH; Whitty GA; Piccoli DS; Hamilton JA
Immunology; 1989 Mar; 66(3):376-83. PubMed ID: 2495247
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
Minty A; Ferrara P; Caput D
Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
[TBL] [Abstract][Full Text] [Related]
8. Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.
Okutomi T; Inagawa H; Nishizawa T; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1990 Dec; 9(6):564-9. PubMed ID: 2074443
[TBL] [Abstract][Full Text] [Related]
9. Induction of membrane-associated interleukin 1 alpha (IL-1 alpha) by synergistic activation of human blood monocytes with interferon gamma and muramyl dipeptide analog.
Okubo A; Sone S; Tanaka M; Fukuta K; Inamura N; Nakanishi M; Maeda K; Yanagawa H; Nishioka Y; Yamashita C
Tokushima J Exp Med; 1989 Dec; 36(3-4):97-105. PubMed ID: 2484023
[TBL] [Abstract][Full Text] [Related]
10. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of tumour necrosis factor production and sensitivity to interleukin-2 of human peripheral blood mononuclear cells stimulated by lipopolysaccharide and muramyl dipeptide in vitro.
Rakhmilevich AL; Shneiderova MA; Korobko VG; Chuvpilo SA
Biomed Sci; 1990; 1(5):517-23. PubMed ID: 2133069
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
14. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
15. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tumour necrosis factor production with desmuramyldipeptide analogues.
Simcic S; Wraber B; Sollner M; Urleb U; Gobec S
Pflugers Arch; 2000; 440(5 Suppl):R64-6. PubMed ID: 11005615
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
Dubois C; Bissonnette E; Rola-Pleszczynski M
J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
[TBL] [Abstract][Full Text] [Related]
18. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
Wanidworanun C; Strober W
J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
[TBL] [Abstract][Full Text] [Related]
19. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
[TBL] [Abstract][Full Text] [Related]
20. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
Mizuno K; Okamoto H; Horio T
J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
